Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Mouwasat Medical Services Co EV-to-EBITDA?
Mouwasat Medical Services CoSAU:4002 +0.31%100 EV-to-EBITDA is 12.14 as of Sep. 06, 2026, which is 40% below its 10-year median of 20.12. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼102.64 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks worse than 56.53% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Mouwasat Medical Services Co's enterprise value is ﷼14,269 Mil.
Mouwasat Medical Services Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼1,176 Mil. Therefore, Mouwasat Medical Services Co's EV-to-EBITDA for today is 12.14.
The historical rank and industry rank for Mouwasat Medical Services Co's EV-to-EBITDA or its related term are showing as below:
SAU:4002'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.21 Med: 20.12 Max: 32.73
Current: 12.14
During the past 13 years, the highest EV-to-EBITDA of Mouwasat Medical Services Co was 32.73. The lowest was 11.21. And the median was 20.12.
SAU:4002's EV-to-EBITDA is ranked worse than 56.53% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.51
vs SAU:4002: 12.14
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Mouwasat Medical Services Co (SAU:4002) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mouwasat Medical Services Co's PE Ratio (TTM) for today is calculated as:
Mouwasat Medical Services Co's share price for today is ﷼65.50.
Mouwasat Medical Services Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼4.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4002 vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's EV-to-EBITDA falls into.
Mouwasat Medical Services Co's current Enterprise Value is ﷼14,269 Mil.
Mouwasat Medical Services Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼1,176 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co (SAU:4002) has a EV-to-EBITDA of 12.14 as of Sep. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Mouwasat Medical Services Co. This is 40% below median its historical median of 20.12. Over the past decade, Mouwasat Medical Services Co's EV-to-EBITDA has ranged from 11.21 to 32.73. According to the industry distribution chart, Mouwasat Medical Services Co ranks #290 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 56.5%.
Is Mouwasat Medical Services Co's EV-to-EBITDA too high?
Mouwasat Medical Services Co's current EV-to-EBITDA of 12.14 is 40% below median its 10-year median of 20.12. Over the past 10 years, this metric has ranged from a low of 11.21 to a high of 32.73. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.51. Mouwasat Medical Services Co's value of 12.14 is 15.5% above this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #290 out of 513 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #290 out of 513 companies for EV-to-EBITDA. This places Mouwasat Medical Services Co in the lower half of its industry. The industry median EV-to-EBITDA is 10.51. Mouwasat Medical Services Co's value of 12.14 is 15.5% above this benchmark. Historically, Mouwasat Medical Services Co's own EV-to-EBITDA has ranged from 11.21 to 32.73 over the past decade. While the company's 10-year median is 20.12 vs. the industry median of 10.51, Mouwasat Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.51, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current EV-to-EBITDA of 12.14 is 15.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Mouwasat Medical Services Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current EV-to-EBITDA is 12.14, which is 40% below median its own 10-year median of 20.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼102.64, compared to a current price of ﷼65.50 — trading 36.2% below its estimated fair value. The current EV-to-EBITDA is 12.14, which is 40% below median its 10-year median of 20.12 and 15.5% above the Healthcare Providers & Services industry median of 10.51. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current EV-to-EBITDA is 12.14 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼65.50 is trading 36.2% below its estimated GF Value™ of ﷼102.64.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
EV-to-EBITDA: 12.14 (40% below median its 10-year median of 20.12)
GF Value™: ﷼102.64 vs. price of ﷼65.50 (36.2% below fair value)
Industry Position: 15.5% above the Healthcare Providers & Services median (#290 of 513)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
